Rolvedon 13.2 mg/0.6 mL single-dose prefilled syringe Images
Generic Name: eflapegrastim
This medication has been identified as Rolvedon 13.2 mg/0.6 mL single-dose prefilled syringe. It is supplied by Spectrum Pharmaceuticals, Inc.
Rolvedon is used in the treatment of Neutropenia Associated with Chemotherapy and belongs to the drug class colony stimulating factors. Rolvedon 13.2 mg/0.6 mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rolvedon
- Generic Name
- eflapegrastim
- Strength
- 13.2 mg/0.6 mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- Colony stimulating factors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Spectrum Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 76961-0101
See also:
Zarxio
Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with ...
Neulasta
Neulasta is used to stimulate neutrophil growth and reduce infection risk (manifested by febrile ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Neupogen
Neupogen (filgrastim) is used to treat neutropenia, a lack of certain white blood cells caused by ...
Fulphila
Fulphila is used for febrile neutropenia, neutropenia associated with chemotherapy
Nivestym
Nivestym is used for bone marrow transplantation, neutropenia, neutropenia associated with ...
Udenyca
Udenyca is used for febrile neutropenia, hematopoietic syndrome of acute radiation syndrome ...
Releuko
Releuko is used for bone marrow transplantation, neutropenia, neutropenia associated with chemotherapy
More about Rolvedon (eflapegrastim)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: colony stimulating factors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.